Know Cancer

or
forgot password

Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer


N/A
18 Years
90 Years
Not Enrolling
Both
Chronic Pancreatitis, Pancreatic Cancer

Thank you

Trial Information

Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer


Inclusion Criteria:



- Normal subjects - No documented clinical history of pancreatic diseases supported by
at least 1 negative imaging test. (EUS, Ct scan or MRI)

- Chronic pancreatitis - Documented diagnosis of moderate to advanced chronic
supported bpancreatitisy at least 1 positive imaging test. (EUS, Ct scan or MRI)

- Pancreatic Cancer - Documented tissue diagnosis (or clinical suspicion) of Pancreatic
Cancer.

Exclusion Criteria:

- Exclusion criteria will include age younger than 18 yrs, pregnancy, previous
pancreatic or gastric resection, and inability to tolerate routine endoscopy with
conscious sedation

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

All cause mortality

Outcome Time Frame:

One year

Safety Issue:

No

Principal Investigator

Massimo Raimondo, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Food and Drug Administration

Study ID:

07-000099

NCT ID:

NCT00851955

Start Date:

May 2007

Completion Date:

November 2011

Related Keywords:

  • Chronic Pancreatitis
  • Pancreatic Cancer
  • Pancreatic Neoplasms
  • Pancreatitis
  • Pancreatitis, Chronic

Name

Location

Mayo ClinicJacksonville, Florida  32224